Virus like particle-based vaccines against emerging infectious disease viruses. - Test2 - elhamkhani - TriplyDB

Virus like particle-based vaccines against emerging infectious disease viruses.

Virus like particle-based vaccines against emerging infectious disease viruses.

http://www.wikidata.org/entity/Q30249025

about

Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.MultiBac: from protein complex structures to synthetic viral nanosystems.Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice.

P2860

Q33622211-C677C3E1-0294-4A13-925D-556D0B84ADCA Q37634520-0DF10923-7288-4EFF-A1D5-2FF384A39BB1 Q46885704-292DD6B8-7A57-4FF6-BAB3-DC326ECA4A17 Q54558196-A520B68F-FC18-4F6A-868D-AC6CD02E1767

P2860

Virus like particle-based vaccines against emerging infectious disease viruses.

http://www.wikidata.org/entity/Q30249025

description

2016 nî lūn-bûn

@nan

2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Virus like particle-based vaccines against emerging infectious disease viruses.

@ast

Virus like particle-based vaccines against emerging infectious disease viruses.

@en

type

label

Virus like particle-based vaccines against emerging infectious disease viruses.

@ast

Virus like particle-based vaccines against emerging infectious disease viruses.

@en

prefLabel

Virus like particle-based vaccines against emerging infectious disease viruses.

@ast

Virus like particle-based vaccines against emerging infectious disease viruses.

@en

P1433

Q30249025-71E11D1C-68E4-4E91-8AD0-BC1A38CA18A8

P1476

Q30249025-2AA943D3-C26F-470C-AAFA-814408DDC0AC

P2093

Q30249025-4D658998-5E86-46E2-BCC3-D556E1E3E696

Q30249025-6558C8F5-3938-4281-9459-EDF4BD905444

Q30249025-6BD3A1EB-6246-4D86-967A-974847DE9722

Q30249025-8DEF5C52-F7E5-4BD5-ABC9-79DF2AE74381

Q30249025-9CACF9D7-B902-4D7E-995C-E8E6620A1B3F

P2860

Q30249025-036D285C-8C05-4C70-8C97-77540DC40E5B

Q30249025-055C8F2B-10FC-4370-82F2-8E72D6B11236

Q30249025-085C54C4-8266-4F1C-A19B-61AE4E86792B

Q30249025-0A237DF3-74DF-44F4-A65E-B15AFE5BC2E0

Q30249025-0B5DE77C-EB3A-49E2-8B9B-ADD96151E046

Q30249025-0CA39DB2-CE3F-4756-94F5-846144C82C13

Q30249025-0E73EE1B-6D55-4DB5-908D-29978D3D2034

Q30249025-16A87BCE-4E17-4E00-9B74-DEFB0453DACC

Q30249025-19C07E95-E913-4781-845A-5E4975124E19

Q30249025-1B6AD300-075A-4F79-ABD2-5ADA52E3DB78

P2888

Q30249025-7EA1B77D-ABFA-4617-B41E-EE63BA231CEF

P304

Q30249025-189D26F2-2D9E-456E-960A-EE0336A4E55B

P31

Q30249025-EEC954CB-AD70-484B-B723-591CE1A9E42C

P356

Q30249025-ED0C455E-7EB5-433E-8A8E-A8A3B1A85C2B

P433

Q30249025-027B35B9-C9D0-454B-9AF1-2991A9152A51

P478

Q30249025-660BC593-6177-4AD2-A52A-0F5BF6BBB907

P50

Q30249025-1C88BA04-42B0-4A85-A41C-8E53624F7877

P577

Q30249025-4DAB9205-E79A-475B-96FA-B7DA60CCF538

P6179

Q30249025-D595D80A-8F1C-4B26-8A89-3CE67CB41848

P698

Q30249025-92CAC31B-7DCE-49EF-AE5B-CDE136448E41

P932

Q30249025-8F03E27F-07B4-4216-93C0-AA4DE65B489B

P356

S12250-016-3756-Y

P1433

Virologica Sinica

P1476

Virus like particle-based vaccines against emerging infectious disease viruses.

@en

P2093

Fei Deng

http://www.w3.org/2001/XMLSchema#string

Hualin Wang

http://www.w3.org/2001/XMLSchema#string

Jinliang Liu

http://www.w3.org/2001/XMLSchema#string

Manli Wang

http://www.w3.org/2001/XMLSchema#string

Shiyu Dai

http://www.w3.org/2001/XMLSchema#string

P2860

Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

Human Norovirus as a Foodborne Pathogen: Challenges and Developments

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

Emergence of Zaire Ebola Virus Disease in Guinea

Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections.

Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice

The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza.

Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

P2888

s12250-016-3756-y

P304

279-287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12250-016-3756-Y

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051462813

http://www.w3.org/2001/XMLSchema#string

P698

27405928

http://www.w3.org/2001/XMLSchema#string

P932

7090901

http://www.w3.org/2001/XMLSchema#string